Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy OpGen stock
Learn how to easily invest in OpGen stock.
OpGen Inc is a diagnostics & research business based in the US. OpGen shares (OPGN) are listed on the NASDAQ and all prices are listed in US Dollars. OpGen employs 91 staff and has a trailing 12-month revenue of around $4.1 million.
How to buy shares in OpGen
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – OPGN – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
OpGen stock price (NASDAQ: OPGN)Use our graph to track the performance of OPGN stocks over time.
OpGen shares at a glance
|Latest market close||$0.29|
|52-week range||$0.31 - $3.55|
|50-day moving average||$0.50|
|200-day moving average||$0.69|
|Wall St. target price||$1.84|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.83|
Buy OpGen shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy OpGen stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
OpGen price performance over time
|1 week (2022-09-23)||-26.08%|
|1 month (2022-08-30)||-40.36%|
|3 months (2022-07-01)||-49.97%|
|6 months (2022-04-01)||-61.97%|
|1 year (2021-10-01)||-89.63%|
|2 years (2020-10-02)||-86.69%|
|3 years (2019-10-02)||6.84|
|5 years (2017-09-29)||0.31|
|Revenue TTM||$4.1 million|
|Gross profit TTM||$-9,453,096|
|Return on assets TTM||-23.42%|
|Return on equity TTM||-76.05%|
|Market capitalisation||$18.7 million|
TTM: trailing 12 months
OpGen share dividends
We're not expecting OpGen to pay a dividend over the next 12 months.
Have OpGen's shares ever split?
OpGen's shares were split on a 1:20 basis on 28 August 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OpGen shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for OpGen shares which in turn could have impacted OpGen's share price.
OpGen share price volatility
Over the last 12 months, OpGen's shares have ranged in value from as little as $0.31 up to $3.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OpGen's is -0.3759. This would suggest that OpGen's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OpGen has bucked the trend.
OpGen, Inc. , a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc.
OpGen in the news
OpGen Announces $3.38 Million Registered Direct Offering
OpGen Subsidiary Curetis and FIND Sign R&D Collaboration Agreement for Unyvero A30 RQ Platform
OpGen Announces Participation at the H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of OpGen is owned by insiders or institutions?
Currently 0.578% of OpGen shares are held by insiders and 7.241% by institutions. How many people work for OpGen?
Latest data suggests 91 work at OpGen. When does the fiscal year end for OpGen?
OpGen's fiscal year ends in December. Where is OpGen based?
OpGen's address is: 9717 Key West Avenue, Rockville, MD, United States, 20850 What is OpGen's ISIN number?
OpGen's international securities identification number is: US68373L3078 What is OpGen's CUSIP number?
OpGen's Committee on Uniform Securities Identification Procedures number is: 68373L109
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert